Literature DB >> 15641147

Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome.

Hui-Ying Zhang1, De-Wu Han, Xin-Guo Wang, Yuan-Chang Zhao, Xin Zhou, Hai-Zhen Zhao.   

Abstract

AIM: To evaluate the role of intestinal endotoxemia in the genesis of hepatopulmonary syndrome.
METHODS: A rat model of cirrhosis was prepared with the method of compound factors. At the end of the eighth week, rats with cirrhosis were treated with 300 microg LPS/100 g body weight, and 1 g/rat of glycine about four h prior to LPS. After three h of LPS treatment, blood and tissues were collected for various measurements. Kupffer cells were isolated from male Wistar rats and cultured, and divided into five groups. Supernatant was harvested at 3 h after treatment with LPS for measurement of tumor necrosis factor-alpha (TNF-alpha).
RESULTS: Our results showed that in rats with cirrhosis, slowed and deepened breath with occasional pause was. PaO2, PaCO2 and standard bicarbonate (SB) in arterial blood were decreased. Arterial O2 and actual bicarbonate (AB) were markedly decreased. There was a close correlation between decreased O2 and endotoxin. Metabolic acidosis accompanying respiratory alkalosis was the primary type of acid-base imbalance. The alveolar-arterial oxygen gradient was sharply widened. Massive accumulation of giant macrophages in the alveolar spaces and its wall and widened alveolar wall architecture were observed. The number of bacterial translocations in mesenteric lymph nodes increased. The ratio of TC99M-MAA brain-over-lung radioactivity rose. Endotoxin, and TNF-alpha, endothelin-1 (ET-1), nitric oxide (NO) in plasma and ET-1, carbon monoxide (CO) in lung homogenates increased. After administration of a given dosage of LPS in rats with cirrhosis, various pathological parameters worsened. Plasma level of endotoxin was related to TNF-alpha, ET-1, NO in plasma and ET-1, NO, CO in lung homogenates. TNF-alpha level was related to ET-1 and NO in plasma and lung homogenates and CO in lung homogenate as well. The level of TNF-alpha increased after infusion of LPS into culture supernatant of Kupffer cells in vitro. However, TNF-alpha significantly decreased after pretreatment with glycine, PD98059 and SB212850. Glycine could antagonize the effect of LPS in vivo and in vitro.
CONCLUSION: Intestinal endotoxemia accompanying by cirrhosis may be an important mechanism in the development of hepatopulmonary syndrome in rats. Overproduction of TNF-alpha due to endotoxin stimulation of Kupffer cells via mitogen-activated protein kinase (MAPK) signal transduction pathway may be a major mechanism mediating the pathologic alterations of hepatopulmonary syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15641147      PMCID: PMC4250812          DOI: 10.3748/wjg.v11.i4.567

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control.

Authors:  L Jia; C Bonaventura; J Bonaventura; J S Stamler
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

Review 3.  Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations.

Authors:  M J Krowka; D A Cortese
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

Review 4.  Endothelin peptides: biological actions and pathophysiological significance in the lung.

Authors:  J G Filep
Journal:  Life Sci       Date:  1993       Impact factor: 5.037

Review 5.  Clinical management of hepatopulmonary syndrome.

Authors:  M J Krowka
Journal:  Semin Liver Dis       Date:  1993-11       Impact factor: 6.115

Review 6.  Intestinal endotoxemia as a pathogenetic mechanism in liver failure.

Authors:  De-Wu Han
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

Review 7.  Heme oxygenase: colors of defense against cellular stress.

Authors:  L E Otterbein; A M Choi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-12       Impact factor: 5.464

8.  Nitric oxide in the human respiratory cycle.

Authors:  Timothy J McMahon; Richard E Moon; Ben P Luschinger; Martha S Carraway; Anne E Stone; Bryant W Stolp; Andrew J Gow; John R Pawloski; Paula Watke; David J Singel; Claude A Piantadosi; Jonathan S Stamler
Journal:  Nat Med       Date:  2002-06-03       Impact factor: 53.440

9.  Endothelin-1 in the rat bile duct ligation model of hepatopulmonary syndrome: correlation with pulmonary dysfunction.

Authors:  B Luo; G A Abrams; M B Fallon
Journal:  J Hepatol       Date:  1998-10       Impact factor: 25.083

10.  Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury.

Authors:  Ana J Coito; Roland Buelow; Xiu-Da Shen; Farin Amersi; Carolina Moore; Hans-Dieter Volk; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2002-07-15       Impact factor: 4.939

View more
  18 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 2.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

Review 3.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

4.  Salvianolate inhibits cytokine gene expression in small intestine of cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Bo Jin; Xu-Jun He; Qin Zhang; Wei-Ming Zhou; Wen-Juan Xu; Huo-Xiang Lu
Journal:  World J Gastroenterol       Date:  2011-04-14       Impact factor: 5.742

Review 5.  Potential Clinical Targets in Hepatopulmonary Syndrome: Lessons From Experimental Models.

Authors:  Sarah Raevens; Michael B Fallon
Journal:  Hepatology       Date:  2018-11       Impact factor: 17.425

6.  Effect of salvianolate on intestinal epithelium tight junction protein zonula occludens protein 1 in cirrhotic rats.

Authors:  Dan-Hong Yang; Zai-Yuan Ye; Yuan-Jun Xie; Xu-Jun He; Wen-Juan Xu; Wei-Ming Zhou
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

7.  Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.

Authors:  Yun-Xia Chen; Li-Na Lai; Hui-Ying Zhang; Yang-Hui Bi; Li Meng; Xu-Jiong Li; Xiao-Xia Tian; Li-Min Wang; Yi-Min Fan; Zhong-Fu Zhao; De-Wu Han; Cheng Ji
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

8.  The effects of flavanoid on the treatment of hepatopulmonary syndrome.

Authors:  Talha Atalay; Murat Cakir; Ahmet Tekin; Tevfik Kucukkartallar; Suleyman Kargin; Adil Kartal; Adnan Kaynak
Journal:  J Korean Surg Soc       Date:  2013-10-25

9.  Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.

Authors:  Ki Tae Suk; Moon Young Kim; Soung Won Jeong; Jae Young Jang; Yoon Ok Jang; Soon Koo Baik
Journal:  Dig Dis Sci       Date:  2017-12-01       Impact factor: 3.199

Review 10.  Cirrhosis and hepatopulmonary syndrome.

Authors:  Gokhan Tumgor
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.